Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users. An Advisory Committee Statement (ACS).
D000328:Adult; D000416:Alberta / Q000453:epidemiology; D001955:British Columbia / Q000453:epidemiology; D002170:Canada / Q000453:epidemiology; D004196:Disease Outbreaks / Q000517:prevention & control; D006703:Ill-Housed Persons; D006801:Humans; D017589:Immunization Programs; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D015819:Substance Abuse, Intravenous / Q000150:complications
C414006:23-valent pneumococcal capsular polysaccharide vaccine; D022242:Pneumococcal Vaccines